Edwards Lifesciences Corp (EW)
Fixed asset turnover
Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
---|---|---|---|---|---|---|
Revenue | US$ in thousands | 5,439,500 | 6,004,800 | 5,382,400 | 5,232,500 | 4,386,300 |
Property, plant and equipment | US$ in thousands | — | — | 1,725,100 | 1,638,700 | 1,395,200 |
Fixed asset turnover | — | — | 3.12 | 3.19 | 3.14 |
December 31, 2024 calculation
Fixed asset turnover = Revenue ÷ Property, plant and equipment
= $5,439,500K ÷ $—K
= —
The fixed asset turnover ratio of Edwards Lifesciences Corp has shown a steady performance over the past few years. In 2020, the ratio stood at 3.14, slightly increasing to 3.19 in 2021 before decreasing to 3.12 in 2022. However, the data is not available for the years 2023 and 2024.
The fixed asset turnover ratio measures how efficiently the company is generating revenues from its investment in fixed assets. A higher fixed asset turnover ratio indicates that the company is using its fixed assets more efficiently to generate sales.
While the slight fluctuations in the ratio over the years may indicate changes in efficiency in utilizing fixed assets, it is important to note that the ratio is a metric that should be analyzed alongside other financial indicators to gain a comprehensive understanding of the company's operational efficiency and asset management strategies.
Peer comparison
Dec 31, 2024